Literature DB >> 21088467

Secondary aneurysmal bone cyst of the patella.

Firat Ozan1, Gökhan Toker.   

Abstract

Aneurysmal bone cyst accounts for 1% of primary bone tumors and is one of the benign tumor-like lesions. Patellar involvement is quite rare. Its development on the basis of any previous lesion such as chondroblastoma is called secondary aneurysmal bone cyst. A 26-year-old male patient presented with right knee pain of three-year history. Physical examination showed a firm, immobile swelling at the anterior aspect of the right knee, without increase in temperature or redness of the skin. There was no pain on palpation and joint range of motion was normal. Radiological studies were suggestive of an aneurysmal bone cyst. At surgery, the cystic lesion was removed via curettage and the residual cavity was filled with an autogenous bone graft taken from the iliac wing. The histopathologic diagnosis was secondary aneurysmal bone cyst in association with chondroblastoma. During a 1.5-year follow-up, the patient had no complaint and no recurrence was observed.

Entities:  

Mesh:

Year:  2010        PMID: 21088467     DOI: 10.3944/AOTT.2010.2078

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


  3 in total

1.  Secondary aneurysmal bone cyst following chondroblastoma of the patella.

Authors:  Kato Tomoyuki; Michiro Susa; Robert Nakayama; Itsuo Watanabe; Keisuke Horiuchi; Yoshiaki Toyama; Hideo Morioka
Journal:  Rare Tumors       Date:  2013-09-04

Review 2.  Primary and Metastatic Bone Tumors of the Patella: Literature Review and Institutional Experience.

Authors:  Nelson Merchán; Caleb M Yeung; Jayden Garcia; Joseph H Schwab; Kevin A Raskin; Erik T Newman; Santiago A Lozano-Calderón
Journal:  Arch Bone Jt Surg       Date:  2022-02

Review 3.  Chondroblastoma of the patella with secondary aneurysmal bone cyst, an easily misdiagnosed bone tumor:a case report with literature review.

Authors:  Jianping Zheng; Ningkui Niu; Jiandang Shi; Xu Zhang; Xi Zhu; Jiali Wang; Changhao Liu
Journal:  BMC Musculoskelet Disord       Date:  2021-04-23       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.